30 completed, 1 not yet recruiting, 1 unknown, 1 withdrawn. 33 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 33 | Completed 30, Not yet recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 2 |
Follow Teriparatide: new trials by email Literature Review of Teriparatide trials Research Report on Teriparatide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture QLG2128, Teriparatide Injection - Postmenopausal Women With Osteoporosis | Phase 3 | Not yet recruiting | Qilu Pharmaceutical Co., Ltd. | 282 | 2025-06-01 | 2025-03-27 |
| To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk SAL056 (56.5μg), Alendronate - Postmenopausal Women With Osteoporosis | Phase 3 | Completed | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 493 | 2021-12-03 | 2025-06-25 |
| Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between Sexes Teriparatide - Stress Fracture | Phase 3 | Completed | Norfolk and Norwich University Hospitals NHS Foundation Trust | 30 | 2021-05-24 | 2021-08-12 |
| Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa). Teriparatide - Secondary Hyperparathyroidism, Chronic Kidney Disease-Mineral and Bone Disorder | Phase 3 | Completed | Saint Petersburg State University, Russia | 20 | 2021-03-01 | 2022-11-10 |
| Study of Teriparatide in Stress Fracture Healing Teriparatide - Stress Fracture, Parathyroid Hormone | Phase 3 | Unknown | University of East Anglia | 136 | 2019-12-23 | 2020-11-04 |
| The Effect of Teriparatide on Bone Union in Unstable Intertrochanteric Fracture Patients Treated With PFNA Teriparatide, Placebo, Calcium supplement - Unstable Intertrochanteric Fracture, Pertrochanteric Fracture of Femur, Closed | Phase 3 | Completed | King Chulalongkorn Memorial Hospital | 50 | 2017-05-17 | 2025-01-15 |
| A Comparison of PF708 and Forteo in Osteoporosis Patients Teriparatide (PF708), Teriparatide (Forteo) - Osteoporosis | Phase 3 | Completed | Pfenex, Inc | 181 | 2016-12-01 | 2018-05-23 |
| Teriparatide for Fracture Repair in Humans Teriparatide, Placebo - Osteoporosis, Age-Related, Humeral Fractures | Phase 3 | Withdrawn | Medical University of Vienna | 2014-06-01 | 2015-09-17 | |
| Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical Femur Fractures Teriparatide 20 mcg, Placebo - Non Displaced Atypical Femoral Fractures | Phase 3 | Completed | University Health Network, Toronto | 34 | 2013-07-01 | 2023-06-01 |
| An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women Romozosumab, Teriparatide - Postmenopausal Osteoporosis | Phase 3 | Completed | Amgen | 436 | 2013-01-31 | 2022-11-29 |
| Effect of Teriparatide on Hip Fracture Healing Teriparatide, Placebo, Calcium supplementation - Femur Neck Fracture | Phase 3 | Completed | Eli Lilly and Company | 122 | 2012-02-01 | 2015-04-16 |
| Second Study of the Effect of Teriparatide on Hip Fracture Healing Teriparatide, Placebo, Calcium supplementation - Femur Neck Fracture | Phase 3 | Completed | Eli Lilly and Company | 39 | 2012-01-01 | 2015-04-16 |
| Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women Placebo, BA058 80 mcg, teriparatide - Osteoporosis, Postmenopausal Osteoporosis | Phase 3 | Completed | Radius Health, Inc. | 2463 | 2011-04-01 | 2017-03-01 |
| Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women Teriparatide (PTH 1-34) - Menopause, Fracture | Phase 2 / Phase 3 | Completed | Columbia University | 22 | 2008-08-20 | 2018-07-26 |
| Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy teriparatide - Osteoporosis | Phase 3 | Completed | Eli Lilly and Company | 200 | 2008-01-01 | 2009-07-22 |
| Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis Teriparatide, Risedronate - Osteoporosis | Phase 3 | Completed | Eli Lilly and Company | 92 | 2007-07-01 | 2012-03-13 |
| Phase 3 Clinical Trial of Teriparatide in Japan Teriparatide, Placebo - Osteoporosis | Phase 3 | Completed | Eli Lilly and Company | 207 | 2007-01-01 | 2010-09-21 |
| Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis Zoledronic acid, Placebo, Teriparatide - Osteoporosis | Phase 3 | Completed | Novartis | 412 | 2006-12-01 | 2011-04-20 |
| A Study for Patients With Osteoporosis Teriparatide, Salmon Calcitonin - Osteoporosis | Phase 3 | Completed | Eli Lilly and Company | 364 | 2006-12-01 | 2009-10-28 |
| Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis teriparatide, risedronate, placebo - Osteoporosis, Postmenopausal, Back Pain | Phase 3 | Completed | Eli Lilly and Company | 712 | 2006-06-01 | 2011-05-26 |
Showing 20 of 33. Sign in to see all of them.
Osteoporosis (15) · Osteoporosis, Postmenopausal (9) · Bone Diseases, Metabolic (3) · Femoral Neck Fractures (2) · Fractures, Bone (2) · Fractures, Stress (2) · Hypoparathyroidism (2) · Back Pain (1) · Chronic Kidney Disease-Mineral and Bone Disorder (1) · Humeral Fractures (1) · Hyperparathyroidism, Secondary (1) · Hypocalcemia (1) · Motor Activity (1) · Spinal Fractures (1) · Xanthomatosis, Cerebrotendinous (1)
Eli Lilly and Company (17) · Columbia University (2) · Amgen (1) · John P. Bilezikian (1) · King Chulalongkorn Memorial Hospital (1) · Medical University of Vienna (1) · Norfolk and Norwich University Hospitals NHS Foundation Trust (1) · Novartis (1) · Pfenex, Inc (1) · Qilu Pharmaceutical Co., Ltd. (1) · Radius Health, Inc. (1) · Saint Petersburg State University, Russia (1) · Shenzhen Salubris Pharmaceuticals Co., Ltd. (1) · University Health Network, Toronto (1) · University of California, San Francisco (1)
United States (15) · Belgium (6) · Canada (6) · Denmark (5) · Spain (5) · Argentina (4) · Austria (4) · Czechia (4) · Germany (4) · Italy (4) · Poland (4) · Australia (3) · China (3) · Hungary (3) · Norway (3)
Adi Cohen, MD (1) · Angela M Cheung, MD, PhD (1) · Christian Muschitz, M.D. (1) · Clifford Rosen, MD (1) · Elizabeth Shane, MD (1)
PMID 18003959, PMID 19250060, PMID 19656016, PMID 19918047, PMID 20580870, PMID 23099796, PMID 23149277, PMID 23322362, PMID 26185429, PMID 27111239, PMID 27533157, PMID 27612281, PMID 27826127, PMID 29972871, PMID 30102789, PMID 31411768, PMID 31674644, PMID 32513495, PMID 32658264, PMID 34231877, PMID 34461961, PMID 36588166, PMID 39999474, PMID 40786602
N01AR002245 (1), R01DK069350 (1)